China Medical Technologies, Inc. was awarded the Conformité Européenne Mark (CE Mark) for two semi-automatic ECLIA analyzers and 15 reagents, including reagents for thyroid disorders, diabetes and tumor markers. The CE Mark indicates the product meets the provisions of the In-Vitro Diagnostic Directive (IVDD) of the European Union. More details...

Stock Symbol: (NSDQ: CMED)